Unusual timing before quarterly is released , comments should be made on what holders are aware of . Cellmid was trading comfortably a few years ago disappointingly at around 60 cents ( 3 cents before consolidation ) this was before holders were aware how well Japan was going , before expansion into China and the United States markets as well as further expansion into Australian markets . Midkine developments have also been made , much slower than many holders expected .
Regarding the United States they should be selling Evolis in stores such as Walgreens where other hair loss products , shampoos are sold as well supplements which compliment them .
Selling in stores such has bloomingdales and neiman marcus is unusual as they are closer to stores in Australia such as David Jones . Good to see they are finally selling at least one product on Amazon .
evolis Professional REVERSE Treatment Mask, Travel Packet, 1 oz
evolis
Be the first to review this item
Regarding China , Alibaba was extremely poorly executed . Firstly they did not include there complete range and prices were similar to what you could buy on ebay , so why would importers wholesalers buy from Alibaba then ? They are no longer selling on Alibaba . As the Asians are very attracted to Australian products , they could maybe even include the Australian Flag on packaging , just an idea . Many listed companies only need to release news that will be selling to China and that has been enough for the stock price to take off before any revenue is received , lack of interest is difficult to understand .
Another capital raising is announced with the stock price trading at 0.46 ( 2.3 cents before consolidation ) . In the past year Cellmid has made some impressive additions to there team .
The CEO has continued to buy shares at market , stock price has mostly disappointed after her purchases at market . In my opinion , market has lost confidence in current management , question is are the purchases at market because of confidence or are they because of additional power at Cellmid .
I have nothing against current management personally but I am concerned about my investment .
Same CEO for over 12 years , surely it is time for a change , new ideas , direction , hunger etc .
The stock price has mostly performed terribly for a long time now with a lack of interest from Investors . Holders should not be afraid of change as nothing changes without it and with a stock price trading at 0.46 ( 0.023 ) it is surely worth considering .
